share_log
Moomoo 24/7 ·  Feb 28 12:49
Palatin Technologies Shares Are Trading Lower After the Company Announced Results for Its PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients With Dry Eye Disease Did Not Meet Co-primary Sign Endpoints and Secondary Sign Endpoints
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment